| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |